Dr Sayyidi Hamzi bin Dato’ Abdul Raub
Senior Manager, Sub Region Central,
Strategic Planning & Innovation
Premier Integrated Labs Sdn. Bhd, Malaysia
Virtual Expert Exchange
Thursday, 12 November 2026
14:00 - 15:00 (GMT+8)
View other Time Zones
As precision oncology continues to evolve, robust quality assurance in pathology laboratories is more important than ever to ensure reliable biomarker testing and support confident clinical decision-making. We are pleased to invite you to an exclusive session focused on quality assurance in precision oncology biomarker testing.
During this session, experts will exchange practical insights on key QA practices in pathology laboratories, including the use of positive and negative controls, validation versus verification of novel biomarker assays, and lessons learned from External Quality Assessment (EQA) programs such as NordiQC and UK NEQAS. The discussion will also address audience input and real-world challenges, creating an opportunity for interactive exchange and shared learning.
Join this dynamic conversation to explore how pathology laboratories can further strengthen quality, consistency, and confidence in precision oncology testing.
Who should attend:
- This session is highly relevant for lab directors, lab managers, pathologists, trainees/residents and lab technicians in pathology labs
Key reasons to attend:
- In-depth understanding of quality assurance and key steps in quality management in pathology labs.
- Hands-on experience in an External Quality Assessment (EQA).
- Case studies and real-world applications.
Experts
 |
|
Dr Sayyidi Hamzi bin Dato’ Abdul RaubSenior Manager, Sub Region Central, |
Dr. Sayyidi Hamzi Abdul Raub is a senior clinical scientist and innovation leader specializing in molecular diagnostics, cancer genomics, and precision pathology. As the Senior Manager for Research, Development, and Innovation at Pantai Premier Pathology, he has spearheaded the establishment of advanced diagnostic laboratories for cytogenetics, histology, molecular diagnostics, and next-generation sequencing (NGS). Dr. Hamzi brings extensive hands-on experience in histology, including immunohistochemistry and paraffin tissue processing, as well as deep expertise in digital pathology, having implemented AI-driven digital pathology platforms and workflow optimization across clinical labs. A frequent speaker at regional and international conferences, he shares insights from his work at the intersection of lab science, technology, and patient care. Dr. Hamzi is passionate about advancing precision medicine and enabling genomic solutions in routine clinical practice.
 |
Dr Anne WaydelichLab Manager |
|
Dr Anne WaydelichLab Manager |
Anne Waydelich works at Roche Tissue Diagnostics within the Medical and Scientific Affairs group in the EMEA LATAM region (Europe, Middle East, Africa and Latin America) and manages the RTD EMEA-LATAM Research & Quality control laboratory. Anne joined Roche (Ventana) in 2001 as customer support representative for the newly created division taking care of research customers (Discovery platforms). Since then, she held various functions in the Roche Tissue Diagnostics EMEA-LATAM customer support organization. She has achieved in 1999 a PhD in Molecular and Cellular Biology at University Louis Pasteur, Strasbourg, France.
 |
Dr Richie LazaroMedical Affairs Lead-Pathology, |
|
Dr Richie LazaroMedical Affairs Lead-Pathology, |
Dr. Richie Lazaro is Regional Pathologist for Roche Diagnostics Asia Pacific. She previously served as Associate Pathology Director at Q2 Solutions and worked at Singapore General Hospital, specializing in breast and urologic pathology, and leading its digital pathology pilot. A second-generation pathologist, she has led multiple labs in the Philippines, established the first FNA clinic in her province, and taught at the University of St. La Salle College of Medicine. She holds fellowships with the Philippine Society of Pathologists, Singapore Academy of Medicine, and UK Royal College of Pathologists, and has numerous peer-reviewed publications.
Live Webinar Date & Time
 |
Date:Thursday, 12 November 2026 |
 |
|
Can’t make it?
Don’t worry, register now to view the webinar recording after the event.